BMC $89 million in funding to reduce opioid deaths
Boston Medical Center (BMC) was awarded $89 million in funding from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to lead a research study with the goal of reducing opioid deaths by 40% in some of the most heavily impacted Massachusetts communities in three years (MassHEAL). BMC’s study is part of the NIH HEAL (Helping to End Addiction Long-term) Initiative, a bold, trans-agency effort to speed scientific solutions to stem the national opioid crisis.
The CARE Unit faculty, clinical services, and education and training programs are key components of the Grayken Center for Addiction. Information and updates on the Grayken Center for Addiction can be found at www.bmc.org/addiction.